Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Acyclovir placebo
DRUG
2 trials
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
HIV Infections
HIV Seronegativity
Herpes Genitalis
Herpesvirus 2, Human
Phase 2
Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)
Completed
NCT00371592
National Institute of Allergy and Infectious Diseases (NIAID)
Herpesvirus 2, Human, HIV Infections
Start: 2006-09-30
End: 2009-01-31
Target: 50
Updated: 2013-09-23
Phase 3
A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes
Completed
NCT00076232
National Institute of Allergy and Infectious Diseases (NIAID)
Herpes Genitalis, HIV Infections, HIV Seronegativity
Start: 2005-04-30
End: 2007-11-30
Target: 3682
Updated: 2010-12-30
Related Papers
Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.
2010-04-01
19 citations
Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.
2008-06-01
324 citations